Search Results - "Carrasco, F. Henao"

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN by Martínez-Jañez, N., Ezquerra, M. Bellet, Manso Sanchez, L. M., Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V. L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., de la Pena, F. Ayala, Lopez-Tarruella, S., de Araguiz, B. A. Hernando Fernandez, Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J. I., Antón, F. Moreno

“…Purpose To evaluate the efficacy and safety of first-line therapy with palbociclib in a Spanish cohort treated after palbociclib approval. Methods PALBOSPAIN…”
Get full text

Myeloid derived-suppressor cells in healthy women and in advanced breast cancer patients by Palazón Carrión, N., Sánchez León, M.L., Jiménez Cortegana, C., Valdivia García, F.J., Araujo Fernández, I., Henao Carrasco, F., Nieto García, M.A., Sánchez Margalet, V., de la Cruz Merino, L.

Get full text

New horizons in breast cancer: the promise of immunotherapy by de la Cruz-Merino, L., Palazón-Carrión, N., Henao-Carrasco, F., Nogales-Fernández, E., Álamo-de la Gala, M., Vallejo-Benítez, A., Chiesa, M., Sánchez-Margalet, V.

“…Immunology and immunotherapy of cancer is an expanding field in oncology, with recent great achievements obtained through the new successful approaches…”
Get full text

14P Evolution of cytotoxic and regulatory T cells in blood and in tissue after neoadjuvant treatment in breast carcinoma by Palazón Carrión, N., Jiménez Cortegana, C., Sánchez León, M.L., Henao Carrasco, F., Nogales Fernandez, E., Sánchez Margalet, V., de la Cruz Merino, L.

Get full text

354TiP Unraveling trastuzumab emtansine resistance in HER2-positive advanced breast cancer: GEICAM KATIA study by Todo, F. Rojo, Stradella, A., García-Sáenz, J.A., De Las Heras, B. Bermejo, Romero, J.L. Alfonso, Barnadas, A., Peron, Y. Izarzugaza, Alba, E., López-Tarruella, S., Henao-Carrasco, F., Carrasco, E., Caballero, R., Del Campo, M.

Get full text

59PMyeloid derived-suppressor cells in healthy women and in advanced breast cancer patients by Palazón Carrión, N, Sánchez León, M L, Jiménez Cortegana, C, Valdivia García, F J, Araujo Fernández, I, Henao Carrasco, F, Nieto García, M A, Sánchez Margalet, V, de la Cruz Merino, L

Get full text

Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapy by Cortegana, C Jiménez, Carrión, N Palazón, Fernández, E Nogales, García, M A Nieto, Margalet, V Sánchez, de la Gala, M D C Álamo, de Ilárduya, M Suengas Martínez, Burgos, E Montilla, Fernández, I Araújo, Carrasco, F Henao, García-Sancho, A Martín, Carnicero, F., Herranz, E Rios, de la Cruz Vicente, F., Fernández, R., Dominguez, A Rueda, de la Cruz Merino, L.

Get full text

1267P - Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapy by Cortegana, C Jiménez, Carrión, N Palazón, Fernández, E Nogales, García, M A Nieto, Margalet, V Sánchez, de la Gala, M D C Álamo, de Ilárduya, M Suengas Martínez, Burgos, E Montilla, Fernández, I Araújo, Carrasco, F Henao, García-Sancho, A Martín, Carnicero, F., Herranz, E Rios, de la Cruz Vicente, F., Fernández, R., Dominguez, A Rueda, de la Cruz Merino, L.

“…Myeloid derived suppresor cells (MDSC) are a heterogeneous population of immature myeloid cells that inhibits antitumor responses by T lymphocytes. High levels…”
Get full text

1267PEvolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapy by Cortegana, C Jiménez, Carrión, N Palazón, Fernández, E Nogales, García, M A Nieto, Margalet, V Sánchez, de la Gala, M D C Álamo, de Ilárduya, M Suengas Martínez, Burgos, E Montilla, Fernández, I Araújo, Carrasco, F Henao, García-Sancho, A Martín, Carnicero, F, Herranz, E Rios, de la Cruz Vicente, F, Fernández, R, Dominguez, A Rueda, de la Cruz Merino, L

“…Abstract Background Myeloid derived suppresor cells (MDSC) are a heterogeneous population of immature myeloid cells that inhibits antitumor responses by T…”
Get full text

234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study by Anton, F. Moreno, Bellet-Ezquerra, M., Sanchez, L.M. Manso, Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V.L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., Ayala de la Pena, F., Lopez-Tarruella Cobo, S., Hernando Fernandez, B.A., Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J.I., Jañez, N. Martinez

Get full text

146P Updated survival analysis in NEOPERSUR trial: Neoadjuvant pertuzumab in a real-world population in the south of Spain by Gonzalez, A. Falcon, Jurado, J. Cruz, Valenti, E. Llabres, Cubero, R. Urbano, Alamo De La Gala, M.D.C., Martinez, A., Ambite, R.Á., Gonzalez, C.J. Rodriguez, Gongora, M. Amerigo, Perez, L. Rodriguez, Alvarez, M.P. Lopez, Sanchez-Rovira, P., Flores, E. Gonzalez, Carrasco, F. Henao, Calero, J.L. Bayo, Arbizu, M. Valero, Cutillas, A. Quilez, Bofill, F.J. Salvador, Borrego, M. Ruiz

Get full text

1067PPATHOLOGICAL COMPLETE RESPONSE AND CHANGES RELATED TO T INFILTRATING LYMPHOCYTES AND REGULATORY T CELLS IN TISSUE AND PERIPHERAL BLOOD AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CARCINOMA by De La Cruz Merino, L., Barco Sánchez, A., Ibáñez Martínez, J., Nieto García, A., Vallejo Benítez, A., Henao Carrasco, F., Sánchez Margalet, V.

“…Abstract Aim: Some clinical trials in breast cancer have reported imppressive outcomes related to laboratory immune findings in the neoadjuvant setting. In…”
Get full text

Pathological Complete Response and Changes Related to T Infiltrating Lymphocytes and Regulatory T Cells in Tissue and Peripheral Blood After Neoadjuvant Chemotherapy in Breast Carcinoma by De La Cruz Merino, L., Barco Sánchez, A., Ibáñez Martínez, J., Nieto García, A., Vallejo Benítez, A., Henao Carrasco, F., Sánchez Margalet, V.

Get full text